Skip to main content
SpringerLink
Log in
Book cover

Infectiologie en réanimation pp 169–184Cite as

Pneumonies communautaires graves

  • Chapter

  • 1021 Accesses

Part of the book series: Références en réanimation. Collection de la SRLF ((SRLF))

Résumé

Jusqu’à ces dernières années, il était traditionnel de considérer qu’il existait en milieu de réanimation deux types de pneumonies graves: les pneumonies communautaires acquises en ville et les pneumonies nosocomiales qui survenaient au-delà des 48 premières heures d’hospitalisation. Actuellement, il est clair que cette classification dichotomique n’est pas suffisante pour caractériser l’ensemble des pneumonies rencontrées en réanimation. d’une part, il convient de distinguer les pneumonies nosocomiales acquises sous ventilation des autres pneumonies nosocomiales; d’autre part, de nombreux patients bénéficient en dehors d’une hospitalisation traditionnelle de soins ambulatoires tels que chirurgie, dialyse ou chimiothérapie. De même, dans la plupart des structures d’hébergement ou de rééducation, les patients peuvent bénéficier de soins médicaux intensifs ou invasifs. Les pneumonies survenant chez ces patients sont actuellement définies comme liées aux soins [1]. Il convient donc actuellement de considérer comme communautaires les seules pneumonies acquises en ville par des patients indemnes de tout soin ambulatoire récent ou de toute hospitalisation récente. Cette définition stricte étant récente, il est évident que bon nombre des études qui seront citées dans cette revue avaient inclus des patients souffrant de pneumonies liées aux soins.

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Kollef MH, Shorr A, Tabak YP, et al. (2005) Epidemiology and outcomes of healthcare-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 128: 3854–62

    Article  PubMed  Google Scholar 

  2. Fine MJ, Auble TE, Yealy DM, et al. (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336: 243–50

    Article  PubMed  CAS  Google Scholar 

  3. Sligl WI, Eurich DT, Marrie TJ, Majumdar SR (2010) Age still matters: prognosticating short-and long-term mortality for critically ill patients with pneumonia. Crit Care Med 38: 2126–32

    Article  PubMed  Google Scholar 

  4. Mandell LA, Wunderink RG, Anzueto A, et al. (2007) Infectious Disease Society of American/American Thoracic Society consensus guidelines for the management of community acquired pneumonia in adults. Clin Infect Dis 44: S27–72

    Article  PubMed  CAS  Google Scholar 

  5. Brown S, Dean C (2010) Defining and Predicting Severe Community-Acquired Pneumonia. Curr Opin Infect Dis 23: 158–64

    Article  PubMed  Google Scholar 

  6. Ewig S, Ruiz M, Mensa J, et al. (1998) Severe community-acquired pneumonia. Assessment of severity criteria. Am J Respir Crit Care Med 158: 1102–8

    Article  CAS  Google Scholar 

  7. Chalmers JD, Taylor JK, Mandal P, et al. (2011) Validation of the Infectious Diseases Society of America/American Thoratic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care. Clin Infect Dis 53: 503–11

    Article  PubMed  Google Scholar 

  8. Phua J, See KC, Chan YH, et al. (2009) Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia. Thorax 64: 598–603

    Article  PubMed  CAS  Google Scholar 

  9. Charles P, Wolfe R, Whitby M, et al. (2008) SMART-Cop: A tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis 47: 375–84

    Article  PubMed  Google Scholar 

  10. Chalmers J, Mandal P, Singanayagam A, et al. (2011) Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis. Intensive Care Med 37: 1409–20

    Article  PubMed  Google Scholar 

  11. Leroy O (2006) Apport des explorations microbiologiques au diagnostic des infections des voies respiratoires basses. Med Mal Infect 36: 570–98

    Article  PubMed  CAS  Google Scholar 

  12. XVe Conférence de consensus en thérapeutique anti-infectieuse (2006) Prise en charge des infections des voies respiratoires basses de l’adulte immunocompétent. Med Mal Inf 36: 235–44

    Article  Google Scholar 

  13. Leroy O, Saux P Bedos JP et al. (2005) Comparison of levofloxacin and cefotaxime combined with ofloxacin for ICU patients with community-acquired pneumonia who do not require vasopressors. Chest 128: 172–83

    Article  PubMed  CAS  Google Scholar 

  14. Shorr AF, Bodi M, Rodriguez A, et al. (2006) Impact of antibiotic guideline compliance on duration of mechanical ventilation in critically ill patients with community-acquired pneumonia. Chest 130: 93–100

    Article  PubMed  Google Scholar 

  15. Cillöniz C, Ewig S, Polverino E, et al. (2011) Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax 66: 340–6

    Article  PubMed  Google Scholar 

  16. Centre National de Référence des Pneumocoques Rapport d’activité 2009. http://www.invs.sante.fr/surveillance/cnr/rapport_cnrp_2009.pdf

  17. Vardakas KZ, Matthaiou DK, Falagas ME (2009) Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia. Eur Respir J 34: 1148–58

    Article  PubMed  CAS  Google Scholar 

  18. Gillet Y, Vanhems P, Lina G, et al. (2007) Factors predicting mortality in necroti-zing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clin Infect Dis 45: 315–21

    Article  PubMed  Google Scholar 

  19. Shorr AF, Zilberberg MD, Reichley R, et al. (2012) Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. Clin Infect Dis 54: 193–8

    Article  PubMed  Google Scholar 

  20. Beigel JH (2008) Influenza. Crit Care Med 36: 2660–6

    Article  PubMed  Google Scholar 

  21. Martin-Loeches I, Sanchez-Corral A, Díaz E, et al. (2011) Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus. Chest 139: 555–62

    Article  PubMed  Google Scholar 

  22. Catherinot E, Lanternier F, Bougnoux ME, et al. (2010) Pneumocystis jirovecii Pneumonia. Infect Dis Clin North Am 24: 107–38

    Article  PubMed  Google Scholar 

  23. Meehan TP, Fine MJ, Krumholz HM, et al. (1997) Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 278: 2080–4

    Article  PubMed  CAS  Google Scholar 

  24. Houck PM, Bratzler DW, Nsa W, et al. (2004) Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 164: 637–44

    Article  PubMed  Google Scholar 

  25. Kumar A, Roberts D, Wood KE, et al. (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34: 1589–96

    Article  PubMed  Google Scholar 

  26. Puskarich MA, Trzeciak S, Shapiro NI, et al. (2011) Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit Care Med 39: 2066–71

    Article  PubMed  CAS  Google Scholar 

  27. Woodhead M., Blasi F, Ewig S, et al. (2005) Guidelines for the management of adult lower respiratory tract infections Eur Respir J 26: 1138–80

    Article  PubMed  CAS  Google Scholar 

  28. Waterer GW, Somes GW, Wunderink RG (2001) Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med 161: 1837–42

    Article  PubMed  CAS  Google Scholar 

  29. Baddour LM, Yu VL, Klugman KP, et al. (2004) Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med 170: 440–4

    Article  PubMed  Google Scholar 

  30. Martinez JA, Horcajada JP, Almela M, et al. (2003) Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 36: 389–95

    Article  PubMed  CAS  Google Scholar 

  31. Olive D, Georges H, Devos P, et al. (2011) Severe pneumococcal pneumonia: impact of new quinolones on prognosis. BMC Infect Dis 11: 66

    Article  PubMed  CAS  Google Scholar 

  32. 32. Drago L, Nicola L, Rodighiero V, et al. (2011) Comparative evaluation of synergy of combinations of beta-lactams with fluoroquinolones or a macrolide in Streptococcus pneumoniae. J Antimicrob Chemother 66: 845–9

    Article  PubMed  CAS  Google Scholar 

  33. Blot SI, Rodriguez A, Solé-Violán J, et al. (2007) Effects of delayed oxygénation assessment on time to antibiotic delivery and mortality in patients with severe community-acquired pneumonia. Crit Care Med 35: 2509–14

    Article  PubMed  Google Scholar 

  34. Rello J, Catalán M, Díaz E, et al. (2002) Associations between empirical antimicrobial therapy at the hospital and mortality in patients with severe community-acquired pneumonia. Intensive Care Med 28: 1030–5

    Article  PubMed  CAS  Google Scholar 

  35. Brogly N, Devos P, Boussekey N, et al. (2007) Impact of thrombocytopenia on outcome of patients admitted to ICU for severe community-acquired pneumonia. J Infect 55: 136–40

    Article  PubMed  Google Scholar 

  36. Bodí M, Rodriguez A, Solé-Violán J, et al. (2005) Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival. Clin Infect Dis 41: 1709–16

    Article  PubMed  Google Scholar 

  37. Leroy O, Santré C, Beuscart C, et al. (1995) A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Int Care Med 21: 24–31

    Article  CAS  Google Scholar 

  38. Almirall J, Mesalles E, Hamburg J, et al. (1995) Prognostic factors of pneumonia requiring admission to the intensive care unit. Chest 107: 511–6

    Article  PubMed  CAS  Google Scholar 

  39. Wu CL, Lin FJ, Lee SY, et al. (2007) Early evolution of arterial oxygenation in severe community-acquired pneumonia: a prospective observational study. J Crit Care 22: 129–36

    Article  PubMed  Google Scholar 

  40. Boussekey N, Leroy O, Alfandari S, et al. (2006) Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia. Intensive Care Med 32: 469–72

    Article  PubMed  CAS  Google Scholar 

  41. Sligl WI, Eurich DT, Marrie TJ, Majumdar SR (2011) Only severely limited, premorbid functional status is associated with short-and long-term mortality in patients with pneumonia who are critically ill: a prospective observational study. Chest 139: 88–94

    Article  PubMed  Google Scholar 

  42. Restrepo MI, Mortensen EM, Rello J, et al. (2010) Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality. Chest 137: 552–7

    Article  PubMed  Google Scholar 

  43. Leroy O, Devos P, Guery B, et al. (1999) Simplified prediction rule for prognosis of patients with severe community-acquired pneumonia in ICUs. Chest 116: 157–65

    Article  PubMed  CAS  Google Scholar 

  44. Lim WS, Lewis S, Macfarlane JT (2000) Severity prediction rules in community acquired pneumonia: a validation study. Thorax 55: 219–23

    Article  PubMed  CAS  Google Scholar 

  45. Lim WS, van der Eerden MM, Laing R, et al. (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58: 377–82

    Article  PubMed  CAS  Google Scholar 

  46. Aujesky D, Auble TE, Yealy DM (2005) Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med 118: 384–92

    Article  PubMed  Google Scholar 

  47. Leroy O, Mikolajczyk D, Devos P, et al. (2008) Validation of a prediction rule for prognosis of severe community-acquired pneumonia. Open Respir Med J 2: 67–71

    Article  PubMed  Google Scholar 

  48. Rello J, Rodriguez A, Lisboa T, et al. (2009) PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia. Crit Care Med 37: 456–62

    Article  PubMed  Google Scholar 

  49. Amirall J, Bolibar I, Toran P, et al. (2004) Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Chest 125: 1335–42

    Article  Google Scholar 

  50. Simon L, Gauvin F, Amre DK, et al. (2004) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39: 206–17

    Article  PubMed  CAS  Google Scholar 

  51. Maisel A, Neath SX, Landsberg J, et al. (2012) Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial. Eur J Heart Fail 14: 278–86

    Article  PubMed  CAS  Google Scholar 

  52. Masià M, Gutiérrez F, Shum C, et al. (2005) Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients’ outcome research team pneumonia severity index. Chest 128: 2223–9

    Article  PubMed  Google Scholar 

  53. Huang DT, Weissfeld LA, Kellum JA, et al. (2008) Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med 52: 48–58

    Article  PubMed  Google Scholar 

  54. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363: 600–7

    Article  PubMed  CAS  Google Scholar 

  55. Christ-Crain M, Stolz D, Bingisser R, et al. (2006) Procalcitonin-guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 174: 84–93

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de réanimation médicale et maladies infectieuses, Hôpital G. Chatiliez, 135, rue du Président Coty, 59208, Tourcoing cedex, France

    O. Leroy, P. Y. Delannoy, N. Boussekey, A. Meybeck, A. Chiche & H. Georges

Authors
  1. O. Leroy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Y. Delannoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Boussekey
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Meybeck
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Chiche
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Georges
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to O. Leroy .

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Paris

About this chapter

Cite this chapter

Leroy, O., Delannoy, P.Y., Boussekey, N., Meybeck, A., Chiche, A., Georges, H. (2013). Pneumonies communautaires graves. In: Infectiologie en réanimation. Références en réanimation. Collection de la SRLF. Springer, Paris. https://doi.org/10.1007/978-2-8178-0389-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0389-0_11

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0388-3

  • Online ISBN: 978-2-8178-0389-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation